Question

A 72-year-old woman with hypertension and heart failure with reduced ejection fraction (HFrEF) is stable on ramipril and bisoprolol. Her LVEF is 30%, eGFR 68 mL/min/1.73m², and K+ 4.6 mmol/L. Which additional disease-modifying therapy should be added next to reduce hospitalisation and mortality?

Accepted Answer

Dapagliflozin

Answer

Spironolactone

Answer

Furosemide

Answer

Ivabradine

Answer

Digoxin

Practice question

A 72-year-old woman with hypertension and heart failure with reduced ejection fraction (HFrEF) is stable on ramipril and bisoprolol. Her LVEF is 30%, eGFR 68 mL/min/1.73m², and K+ 4.6 mmol/L. Which additional disease-modifying therapy should be added next to reduce hospitalisation and mortality?